S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 8.17 HKD -10.71% Market Closed
Market Cap: 7.9B HKD
Have any thoughts about
Shanghai MicroPort MedBot Group Co Ltd?
Write Note

Shanghai MicroPort MedBot Group Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai MicroPort MedBot Group Co Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Income from Continuing Operations
-ÂĄ1B
CAGR 3-Years
-70%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Income from Continuing Operations
ÂĄ522.1m
CAGR 3-Years
71%
CAGR 5-Years
99%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Income from Continuing Operations
ÂĄ1.7B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
19%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Income from Continuing Operations
ÂĄ12.7B
CAGR 3-Years
19%
CAGR 5-Years
25%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Income from Continuing Operations
ÂĄ701.3m
CAGR 3-Years
-13%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Income from Continuing Operations
ÂĄ2B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort MedBot Group Co Ltd
Glance View

Market Cap
7.8B HKD
Industry
Health Care

Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a surgical robot company dedicated to designing, developing and commercializing surgical robots to assist surgeons in performing complex surgical procedures. The company is headquartered in Shanghai, Shanghai and currently employs 756 full-time employees. The company went IPO on 2021-11-02. The firm's main business is the design, development and commercialization of innovative surgical robots. The firm's products include Toumai Laparoscopic Surgical Robot, DFVision 3D Electronic Laparoscope and Honghu Orthopedic Surgical Robot. The firm's surgical robots are used in multiple minimally invasive surgery fields, including endoscopic surgery, orthopedic surgery, pan-vascular surgery, natural cavity surgery and percutaneous puncture surgery. In addition, the Company also provides education and training services for its surgical robot MedBot.

Intrinsic Value
4.69 HKD
Overvaluation 43%
Intrinsic Value
Price
S

See Also

What is Shanghai MicroPort MedBot Group Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-1B CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort MedBot Group Co Ltd's Income from Continuing Operations amounts to -1B CNY.

What is Shanghai MicroPort MedBot Group Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-70%

Over the last year, the Income from Continuing Operations growth was 11%. The average annual Income from Continuing Operations growth rates for Shanghai MicroPort MedBot Group Co Ltd have been -70% over the past three years .

Back to Top